Insulin resistance is a leading cause of cardiomyopathies by reduced GLUT4 translocation, free fatty acid deposition, and cardiac impairment via altered PI3K-Akt-GLUT4 signaling pathways [164]. This evidence concerns the gene SLC2A4 and cardiomyopathy.